Director of the Center for Infectious Disease Dynamics; Huck Career Development Professor; Professor of Biology
Public Health, Quantitative Epidemiology, Population Ecology, Statistics, Computational and Mathematical Biology
Publication TagsVaccination Measles Disease Outbreaks Population Antibodies Pandemics Health Sars Virus Viruses Vaccines Testing Public Health Neutralizing Antibodies Epidemiology Uncertainty Students Infections Decision Making Liberia Simulation Learning Immunotherapy Immunity Epidemics Incidence
Most Recent Papers
Differential health impact of intervention programs for time-varying disease risk
Allison Portnoy, Yuli Lily Hsieh, Kaja Abbas, Petra Klepac, Heather Santos, Logan Brenzel, Mark Jit, Matthew Ferrari, 2022, BMC Medicine
Large university with high COVID-19 incidence is not associated with excess cases in non-student population
Nita Bharti, Brian Lambert, Cara Exten, Christina Faust, Matthew Joseph Ferrari, Anthony Robinson, 2022, Scientific Reports
COVID-19 Mitigation Among College Students
Rachel A. Smith, Meg L. Small, Nita Bharti, Samuel J. DeMatte, Robert P. Lennon, Matthew Joseph Ferrari, 2022, Health Communication
Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy
Abhinay Gontu, Sreenidhi Srinivasan, Eric Salazar, Meera Surendran Nair, Ruth H. Nissly, Denver Greenawalt, Ian M. Bird, Catherine M. Herzog, Matthew J. Ferrari, Indira Poojary, Robab Katani, Scott E. Lindner, Allen M. Minns, Randall Rossi, Paul A. Christensen, Brian Castillo, Jian Chen, Todd N. Eagar, Xin Yi, Picheng Zhao, Christopher Leveque, Randall J. Olsen, David W. Bernard, Jimmy Gollihar, Suresh V. Kuchipudi, James M. Musser, Vivek Kapur, 2021, Communications Biology
Vaccination strategies for measles control and elimination
F. T. Cutts, M. J. Ferrari, L. K. Krause, A. J. Tatem, J. F. Mosser, 2021, BMC Medicine
The Effects of Using a Clinical Prediction Rule to Prioritize Diagnostic Testing on Transmission and Hospital Burden
Jody R. Reimer, Sharia M. Ahmed, Ben J. Brintz, Rashmee U. Shah, Lindsay T. Keegan, Matthew J. Ferrari, Daniel T. Leung, 2021, Clinical Infectious Diseases on p. 1822-1830
Synergistic interventions to control COVID-19: Mass testing and isolation mitigates reliance on distancing.
E Howerton, M Ferrari, O Bjørnstad, T Bogich, R Borchering, C Jewell, J Nichols, Probert WJM, M Runge, M Tildesley, C Viboud, K Shea, 2021, PLoS Computational Biology on p. e1009518
Modelling the relative benefits of using the measles vaccine outside cold chain for outbreak response
James M. Azam, Barbara Saitta, Kimberly Bonner, Matthew J. Ferrari, Juliet R.C. Pulliam, 2021, Vaccine on p. 5845-5853
Lives saved with vaccination for 10 pathogens across 112 countries in a pre-covid-19 world
Jaspreet Toor, Susy Echeverria-Londono, Xiang Li, Kaja Abbas, Emily D. Carter, Hannah E. Clapham, Andrew Clark, Margaret J. de Villiers, Kirsten Eilertson, Matthew Ferrari, Ivane Gamkrelidze, Timothy B. Hallett, Wes R. Hinsley, Daniel Hogan, John H. Huber, Michael L. Jackson, Kevin Jean, Mark Jit, Andromachi Karachaliou, Petra Klepac, Alicia Kraay, Justin Lessler, Xi Li, Benjamin A. Lopman, Tewodaj Mengistu, C. Jessica E. Metcalf, Sean M. Moore, Shevanthi Nayagam, Timos Papadopoulos, T. Alex Perkins, Allison Portnoy, Homie Razavi, Devin Razavi-Shearer, Stephen Resch, Colin Sanderson, Steven Sweet, Yvonne Tam, Hira Tanvir, Quan Tran Minh, Caroline L. Trotter, Shaun A. Truelove, Emilia Vynnycky, Neff Walker, Amy Winter, Kim Woodruff, Neil M. Ferguson, Katy A.M. Gaythorpe, 2021, eLife
Impact of covid-19-related disruptions to measles, meningococcal a, and yellow fever vaccination in 10 countries
Katy Gaythorpe, Kaja Abbas, John Huber, Andromachi Karachaliou, Niket Thakkar, Kim Woodruff, Xiang Li, Susy Echeverria-Londono, Matthew Ferrari, Michael L. Jackson, Kevin McCarthy, Alex Perkins, Caroline Trotter, Mark Jit, 2021, eLife
Assessment of the 2010 global measles mortality reduction goal
Emily Simons, Matthew Ferrari, John Fricks, Kathleen Wannemuehler, Abhijeet Anand, Anthony Burton, Peter Strebel, 2012, The Lancet on p. 2173--2178
Reduced vaccination and the risk of measles and other childhood infections post-Ebola
Saki Takahashi, C. Jessica E. Metcalf, Matthew J. Ferrari, William J. Moss, Shaun A. Truelove, Andrew J. Tatem, Bryan T. Grenfell, Justin Lessler, 2015, Science on p. 1240--1242
Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
James C. Glasbey, Dmitri Nepogodiev, Joana F.F. Simoes, Omar Omar, Elizabeth Li, Mary L. Venn, Mohammad K.Abou Chaar, Vita Capizzi, Daoud Chaudhry, Anant Desai, Jonathan G. Edwards, Jonathan P. Evans, Marco Fiore, Jose Flavio Videria, Samuel J. Ford, Ian Ganly, Ewen A. Griffiths, Rohan R. Gujjuri, Angelos G. Kolias, Haytham M.A. Kaafarani, Ana Minaya-Bravo, Siobhan C. McKay, Helen M. Mohan, Keith J. Roberts, Carlos San Miguel-Méndez, Peter Pockney, Richard Shaw, Neil J. Smart, Grant D. Stewart, Sudha Sundar, Raghavan Vidya, Aneel A. Bhangu, C. Allemand, L. Boccalatte, M. Figari, M. Lamm, J. Larrañaga, C. Marchitelli, F. Noll, D. Odetto, M. Perrotta, J. Saadi, L. Zamora, C. Alurralde, E. L. Caram, D. Eskinazi, J. P. Mendoza, M. Usandivaras, R. Badra, A. Esteban, 2021, Journal of Clinical Oncology on p. 66-78
Serology for SARS-CoV-2
Juliet E. Bryant, Andrew S. Azman, Matthew J. Ferrari, Benjamin F. Arnold, Maciej F. Boni, Yap Boum, Kyla Hayford, Francisco J. Luquero, Michael J. Mina, Isabel Rodriguez-Barraquer, Joseph T. Wu, Djibril Wade, Guy Vernet, Daniel T. Leung, 2020, Science immunology
Adaptive Management and the Value of Information
Katriona Shea, Michael J. Tildesley, Michael C. Runge, Christopher J. Fonnesbeck, Matthew J. Ferrari, 2014, PLoS Biology on p. e1001970
Understanding Herd Immunity
C. J.E. Metcalf, M. Ferrari, A. L. Graham, B. T. Grenfell, 2015, Trends in Immunology on p. 753-755
Impacto económico estimado de las vacunas en 73 países con ingresos bajos y medios, 2001-2020
Sachiko Ozawa, Samantha Clark, Allison Portnoy, Simrun Grewal, Meghan L. Stack, Anushua Sinha, Andrew Mirelman, Heather Franklin, Ingrid K. Friberg, Yvonne Tam, Neff Walker, Andrew Clark, Matthew Ferrari, Chutima Suraratdecha, Steven Sweet, Sue J. Goldie, Tini Garske, Michelle Li, Peter M. Hansen, Hope L. Johnson, Damian Walker, 2017, Bulletin of the World Health Organization on p. 629-638
Eric T. Lofgren, M. Elizabeth Halloran, Caitlin M. Rivers, John M. Drake, Travis C. Porco, Bryan Lewis, Wan Yang, Alessandro Vespignani, Jeffrey Shaman, Joseph N.S. Eisenberg, Marisa C. Eisenberg, Madhav Marathe, Samuel V. Scarpino, Kathleen A. Alexander, Rafael Meza, Matthew J. Ferrari, James M. Hyman, Lauren A. Meyers, Stephen Eubank, 2014, Proceedings of the National Academy of Sciences of the United States of America on p. 18095-18096
Ebola Cases and Health System Demand in Liberia
John M. Drake, Raj Reni B. Kaul, Laura W. Alexander, Suzanne M. O’Regan, Andrew M. Kramer, J. Tomlin Pulliam, Matthew J. Ferrari, Andrew W. Park, 2015, PLoS Biology on p. e1002056
Decision-making for foot-and-mouth disease control: Objectives matter
William J.M. Probert, Katriona Shea, Christopher J. Fonnesbeck, Michael C. Runge, Tim E. Carpenter, Salome Dürr, M. Graeme Garner, Neil Harvey, Mark A. Stevenson, Colleen T. Webb, Marleen Werkman, Michael J. Tildesley, Matthew J. Ferrari, 2016, Epidemics on p. 10-19
News Articles Featuring Matthew Ferrari
May 27, 2022
Take Note: Penn State infectious disease expert Matthew Ferrari on the COVID-19 pandemic in 2022
COVID-19 cases are climbing again in Pennsylvania and nationally. And so are hospitalizations. Matthew Ferrari, director of Penn State’s Center for Infectious Disease Dynamics, is also part of the research project Data4Action, which has been measuring the impact of the pandemic on the local community for the last two years. WPSU's Anne Danahy spoke with Ferrari about the current upswing in COVID cases, how to understand the data and steps that can be taken in response.
Mar 15, 2022
Rise in COVID cases abroad, presence of omicron subvariant may foreshadow increase in US: Experts
Wastewater data in the U.S. indicates the beginnings of a potential resurgence.
Mar 15, 2022
Rise in COVID-19 infections overseas may foreshadow increase in US, experts say
When the coronavirus receded across much of the globe last month and the omicron surge declined, many Americans were hopeful that was perhaps the signal that the United States was entering a new phase of the pandemic.
Feb 21, 2022
What’s the true covid death toll in Pa.? New analysis sheds light
For many reasons, it’s hard to know the full impact of the covid-19 pandemic. Some deaths may have gone uncounted for reasons such as the person died at home and was never tested. A person may have died from an existing disease exacerbated by covid-19. Or a person may have died from a more indirect result of the pandemic, such as disruption in drug treatment that led to overdose.
Jan 24, 2022
How Centre County school districts are adapting as omicron challenges in-person learning
Unlike last school year, Centre County school districts have avoided a shift to remote learning, and despite the rise of COVID-19 cases, they plan to keep it that way.
Dec 19, 2021
Europe gives US gloomy portrait of what's to come with omicron
As the omicron variant batters Europe with exponentially skyrocketing COVID-19 cases, public health experts warn that the U.S. could be barreling down the same path and face record waves of infections in the coming days and weeks.
Dec 10, 2021
What omicron's fast spread could mean for the U.S. – and the world
The first country to really get hit by omicron is South Africa. Before the new variant took off last month, coronavirus cases there were low – only several hundred per day in mid November. But by early December, the tally of daily infections had shot up to more than 4,500 — and genomic sequencing shows that omicron is to blame.
Dec 02, 2021
Should I be worried about the new omicron coronavirus variant?
The omicron variant (B.1.1.529) of SARS-CoV-2, which has now been detected in the U.S., has been listed as a "variant of concern" by the World Health Organization, which has stated that the overall global risk related to the variant is "very high."
Dec 01, 2021
The Omicron Variant Is a Mystery. Here’s How Science Will Solve It
So far, panic about the new Covid variant has outpaced actual information. Here’s what scientists around the world are trying to uncover.
Nov 15, 2021
End of COVID-19 crisis stage — fingers crossed — might be near
The end of the high-alert, constant worry over COVID-19 might be near — possibly as soon as early next year. We still need to be smart and careful. We must solve a few problems. We also need some good luck.